NCT05617742View on ClinicalTrials.gov

Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST

68Ga-FAPI-46

68Ga-FAPI-46 is a radioactive diagnostic agent for PET imaging in the detection of Fibroblast Activation Protein (FAP) positive tumor cells in cancer patients

Trial Locations (1)

Unknown

RECRUITING

Department of Nuclear Medicine, Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER